Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

TGF-beta1 inhibitor peptides and their use in hepatic diseases described by Spanish group

July 14, 2000

AstraZeneca receives E.U. approval for Nexium

July 14, 2000

KS Biomedix acquires antigen/antibody for ulcerative colitis

July 13, 2000

Final results of phase II study of Synsorb Cd reported by Synsorb Biotech

July 11, 2000

Herbal medicine modulates cytokine production and ameliorates ConA-induced hepatitis

July 10, 2000

Piboserod inhibits increased defecation under stress in preclinical study

July 10, 2000

Hepatoprotective effects of ZNC-2381 described in several experimental models

July 7, 2000

Antioxidant properties of novel ureidophenol derivative T-0970 reported

July 6, 2000

New combination HCV therapy launched in Germany

July 6, 2000

VX-497 plus interferon alfa enters phase II for the treatment of HCV

July 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...